217 related articles for article (PubMed ID: 31108350)
1. Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice.
Gupta AP; Singh P; Garg R; Valicherla GR; Riyazuddin M; Syed AA; Hossain Z; Gayen JR
Biomed Pharmacother; 2019 Aug; 116():108959. PubMed ID: 31108350
[TBL] [Abstract][Full Text] [Related]
2. Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: In vitro and in vivo findings.
Garg R; Gupta AP; Katekar R; Verma S; Goand UK; Dadge S; Gayen JR
Life Sci; 2022 Jan; 289():120221. PubMed ID: 34902437
[TBL] [Abstract][Full Text] [Related]
3. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
4. Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.
Hossain Z; Valicherla GR; Gupta AP; Syed AA; Riyazuddin M; Chandra S; Siddiqi MI; Gayen JR
Sci Rep; 2018 Jun; 8(1):8715. PubMed ID: 29880906
[TBL] [Abstract][Full Text] [Related]
5. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
Gupta AP; Syed AA; Garg R; Goand UK; Singh P; Riyazuddin M; Valicherla GR; Husain A; Gayen JR
Eur J Pharmacol; 2019 Dec; 864():172723. PubMed ID: 31586632
[TBL] [Abstract][Full Text] [Related]
6. Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats.
Valicherla GR; Gupta AP; Hossain Z; Riyazuddin M; Syed AA; Husain A; Lahiri S; Dave KM; Gayen JR
Peptides; 2019 Oct; 120():170147. PubMed ID: 31473204
[TBL] [Abstract][Full Text] [Related]
7. 5-ALA ameliorates hepatic steatosis through AMPK signaling pathway.
Yu H; Zhang M; Ma Y; Lu J; Pan J; Pan P; Chen H; Jia W
J Mol Endocrinol; 2017 Aug; 59(2):121-128. PubMed ID: 28566408
[TBL] [Abstract][Full Text] [Related]
8. Vaccarin ameliorates insulin resistance and steatosis by activating the AMPK signaling pathway.
Lei Y; Gong L; Tan F; Liu Y; Li S; Shen H; Zhu M; Cai W; Xu F; Hou B; Zhou Y; Han H; Qiu L; Sun H
Eur J Pharmacol; 2019 May; 851():13-24. PubMed ID: 30779918
[TBL] [Abstract][Full Text] [Related]
9. Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling.
So WY; Leung PS
Int J Biochem Cell Biol; 2016 Sep; 78():237-247. PubMed ID: 27452313
[TBL] [Abstract][Full Text] [Related]
10. Pancreastatin inhibitor PSTi8 ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production.
Garg R; Katekar R; Parwez S; Agarwal A; Sahu S; Dadge S; Verma S; Goand UK; Siddiqi MI; Gayen JR
Eur J Pharmacol; 2023 Apr; 944():175559. PubMed ID: 36764353
[TBL] [Abstract][Full Text] [Related]
11. Immuno-metabolic effect of pancreastatin inhibitor PSTi8 in diet induced obese mice: In vitro and in vivo findings.
Goand UK; Verma S; Patel I; Tasneem S; Garg R; Gayen JR
Life Sci; 2023 Mar; 316():121415. PubMed ID: 36690247
[TBL] [Abstract][Full Text] [Related]
12. Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice.
Singh P; Garg R; Goand UK; Riyazuddin M; Reza MI; Syed AA; Gupta AP; Husain A; Gayen JR
Heliyon; 2020 Oct; 6(10):e05133. PubMed ID: 33033766
[TBL] [Abstract][Full Text] [Related]
13. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes.
Jeong YT; Kim YD; Jung YM; Park DC; Lee DS; Ku SK; Li X; Lu Y; Chao GH; Kim KJ; Lee JY; Baek MC; Kang W; Hwang SL; Chang HW
Mol Pharmacol; 2013 Jul; 84(1):147-57. PubMed ID: 23658008
[TBL] [Abstract][Full Text] [Related]
15. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
16. Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice.
Zeng HL; Huang SL; Xie FC; Zeng LM; Hu YH; Leng Y
Acta Pharmacol Sin; 2015 Mar; 36(3):343-52. PubMed ID: 25732571
[TBL] [Abstract][Full Text] [Related]
17. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
Patel TP; Rawal K; Soni S; Gupta S
Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
[TBL] [Abstract][Full Text] [Related]
18. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans.
Banerjee J; Bruckbauer A; Zemel MB
Metabolism; 2016 Nov; 65(11):1679-1691. PubMed ID: 27456392
[TBL] [Abstract][Full Text] [Related]
19. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
[TBL] [Abstract][Full Text] [Related]
20. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
